Entering text into the input field will update the search result below

Premarket Gainers as of 9:05 am

Apr. 04, 2017 9:21 AM ETCONN, GBR, CYCC, AFSI, SBSW, PRTK, EVOK, ONTX, HEPA, CRVOBy: Gaurav Batavia, SA News Editor6 Comments
  • GBR +40% on on FY earnings.
  • PRTK +34% on reporting Phase 3 study of omadacycline in community-acquired bacterial pneumonia.
  • CYCC +22%. 
  • CONN +22% on  on Q4 earnings beat.
  • DFFN +24% on on being awarded U.S. Patent for TSC as Therapeutic in Five Hypoxia-Related Indications.
  • ONTX +17% on Positive Preclinical Data for Third-Generation Oral CDK4/6 + ARK5 Inhibitor and dual FLT3 and Src inhibitor.
  • EVOK +16% on positive Type A Meeting with FDA Confirms Acceptability of Pharma’s Proposed Comparative Exposure PK Trial for Gimoti NDA.
  • AFSI +13%.
  • CTRV +7% on reporting new insights into the mechanism of action of its hepatitis B virus-optimized cyclophilin inhibitor CRV431.
  • SBGL +5%.

Recommended For You